Medivolve Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was CAD 3.742 million. Net loss was CAD 8.691 million. Basic loss per share from continuing operations was CAD 0.04. For the half year, sales was CAD 14.990 million. Net loss was CAD 18.675 million. Basic loss per share from continuing operations was CAD 0.1.